Pregnancy
category N/A Legal status Development terminated PubChem CID 11281011 Molar mass 399.86 g/mol | ATC code none CAS Number 847353-30-4 ChemSpider 9456008 | |
 | ||
Arbaclofen placarbil (ar-BAC-loe-fen pla-KAR-bil, also known as XP19986) is a prodrug of R-baclofen. Arbaclofen placarbil possesses more favorable pharmacokinetic profile than baclofen, with less fluctuations in plasma drug levels. It was being developed as a potential treatment for patients with GERD and spasticity due to multiple sclerosis; however, in May 2013 XenoPort announced the termination of development because of unsuccessful results in phase III clinical trials.
References
Arbaclofen placarbil Wikipedia(Text) CC BY-SA